Drug Type Small molecule drug |
Synonyms 1,1'-hexanedioyldi-D-proline, CPHPC, Miridesap (USAN/INN) + [3] |
Target |
Mechanism APCS inhibitors(Serum amyloid P-component inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H24N2O6 |
InChIKeyHZLAWYIBLZNRFZ-VXGBXAGGSA-N |
CAS Registry224624-80-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyloidosis | Phase 2 | - | - | |
Amyloidosis | Phase 2 | - | - | |
Systemic amyloidosis | Phase 1 | GB | 13 Oct 2011 | |
Senile cardiac amyloidosis | Preclinical | GB | 10 Jul 2017 | |
Senile cardiac amyloidosis | Preclinical | US | 10 Jul 2017 |
Phase 1 | 23 | (ntktwccutq) = knebhfsbjz qhdjuwrheq (ywsghuevkf ) | Positive | 09 Jul 2022 | |||
Not Applicable | 5 | acgnuwshzc(vadiysagph) = astzcaogct qnotcfjrie (zbuaadzdkq ) View more | - | 01 Jul 2008 |